Smaller than 100 nanometres in diameter—about 60 times smaller than the width of human hair and comparable in size to microscopic structures within cells—synthetically produced nanoparticles are readily incorporated into biological systems. These ‘ultrafine particles’, which can be produced using several methods, are of increasing scientific interest. Very stable and harmless to plants and … Continue reading
Category Archives: ILVAC
ILRI Vaccine plaform
‘Living tools’ at the frontier of vaccine development—A Keystone Symposium workshop by Vish Nene
Vish Nene, one of the scientific organizers of the conference and a co-leader of the Animal and Human Health program at the International Livestock Research Institute (ILRI), headquartered in Nairobi, Kenya, gave a particularly lucid talk at the pre-meeting workshop on Novel tools and genomics approaches supporting vaccine development. The following is a transcript of Nene’s talk, lightly edited for clarity and brevity. Continue reading
Following the vaccine that wiped out rinderpest, a new vaccine against sheep and goat plague proves promising
A new paper by researchers at ILRI describes development of an effective experimental and thermostable vaccine against ‘peste des petits ruminants’, or PPR for short, a disease more commonly known as sheep and goat plague. Continue reading
Livestock and human health – highlights from ILRI’s corporate report 2015–2016
The experience of the International Livestock Research Institute (ILRI) and partner scientists in 2015–2016 unmistakably identifies the potential benefits to smallholder farmers and consumers of research into livestock and human health. Smallholder farmers could potentially save hundreds of millions of US dollars annually, following breakthroughs in the development of vaccines for contagious bovine pleuropneumonia and Rift Valley fever, the latter posing a serious threat to human as well as animals. However, it was the participation in high-level fora and implementation strategies which are likely to deliver the rapid life changes for smallholder farmers on the ground. Continue reading
A first look at ILRI’s new research programs: Animal and Human Health
A first look at a revamped ILRI research program: Animal and Human Health Continue reading
Vaccine research on Africa’s cattle-killing East Coast fever: A short (somewhat potted but handsomely illustrated) history
Tremendous research progress has been made over the last ten years to better control the deadly African disease of cattle known as East Coast fever. This disease is caused by a single-celled organism, Theileria parva, which is carried by some tick species. Cattle become infected when a tick carrying the parasite takes a blood-meal from the animal over several days. Continue reading
Livestock for better nutrition and disease control–One Health Colloquium held this week at Chatham House
Today and tomorrow (31 May–1 Jun 2016), Chatham House, the Livestock Global Alliance (LGA), the One Health Platform and other One Health partners are convening senior policymakers, academics, multilateral development agencies, business leaders and other private-sector stakeholders to discuss livestock’s role in poverty reduction, sustainable livestock production systems, innovations in livestock vaccines and diagnostics and the value of establishing national and regional One Health centres to provide advice on links among agriculture, sustainable livestock systems and human development. Continue reading
Reverse vaccinology identifies candidates for an improved vaccine against cattle pneumonia in Africa
We used a reverse vaccinology approach to identify 66 Mmm potential vaccine candidates. The selection and grouping of the antigens was based on the presence of specific antibodies in sera from CBPP-positive animals. The antigens were used to immunize male Boran cattle (Bos indicus) followed by a challenge with the Mmm strain Afadé. Continue reading
MERS-CoV antibodies found in two people in eastern Kenya
A new study published in the science journal Emerging Infectious Diseases reports that two individuals in Kenya have tested positive for the presence of antibodies to Middle East Respiratory Syndrome Corona Virus (MERS-CoV). Neither person is ill nor do they recall having any symptoms associated with MERS. There is no evidence of a public health threat and scientists concluded that the infections caused little or no clinical signs of illness. But they plan follow-up studies, as this is the first indication of a MERS-CoV infection that is not connected to primary infections in the Middle East. Continue reading
Vaccine development breakthrough for Rift Valley fever—new Nature Scientific Reports paper
With colleagues from the Jenner and Pirbright institutes in the UK, Nairobi’s Strathmore University and institutions in Saudi Arabia and Spain, scientists and technicians in a vaccine biosciences program of the International Livestock Research Institute (ILRI) in Nairobi, Kenya, have recently published a paper in Nature announcing a breakthrough in development of a ‘One Health’ vaccine that could protect both people and livestock from Rift Valley fever. Continue reading